# Double Filtration Plasmapheresis Combined With Chemotherapy

> **NCT04836871** · PHASE1 · UNKNOWN · sponsor: **Fuling Zhou** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **COMBINATION_PRODUCT:** DFPP combined with chemotherapy

## Key facts

- **NCT ID:** NCT04836871
- **Lead sponsor:** Fuling Zhou
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-15
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-10-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04836871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04836871, "Double Filtration Plasmapheresis Combined With Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04836871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*